132 related articles for article (PubMed ID: 23338213)
1. TokyoGreen derivatives as specific and practical fluorescent probes for UDP-glucuronosyltransferase (UGT) 1A1.
Terai T; Tomiyasu R; Ota T; Ueno T; Komatsu T; Hanaoka K; Urano Y; Nagano T
Chem Commun (Camb); 2013 Apr; 49(30):3101-3. PubMed ID: 23338213
[TBL] [Abstract][Full Text] [Related]
2. An optimized ratiometric fluorescent probe for sensing human UDP-glucuronosyltransferase 1A1 and its biological applications.
Lv X; Ge GB; Feng L; Troberg J; Hu LH; Hou J; Cheng HL; Wang P; Liu ZM; Finel M; Cui JN; Yang L
Biosens Bioelectron; 2015 Oct; 72():261-7. PubMed ID: 25988789
[TBL] [Abstract][Full Text] [Related]
3. A Practical and High-Affinity Fluorescent Probe for Uridine Diphosphate Glucuronosyltransferase 1A1: A Good Surrogate for Bilirubin.
Lv X; Feng L; Ai CZ; Hou J; Wang P; Zou LW; Cheng J; Ge GB; Cui JN; Yang L
J Med Chem; 2017 Dec; 60(23):9664-9675. PubMed ID: 29125289
[TBL] [Abstract][Full Text] [Related]
4. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
5. A Molecular-Splicing Strategy for Constructing a Near-Infrared Fluorescent Probe for UDP-Glucuronosyltransferase 1A1.
Tian X; Liu T; Ma Y; Gao J; Feng L; Cui J; James TD; Ma X
Angew Chem Int Ed Engl; 2021 Nov; 60(46):24566-24572. PubMed ID: 34431597
[TBL] [Abstract][Full Text] [Related]
6. The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
Liu Y; She M; Wu Z; Dai R
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):386-93. PubMed ID: 20939765
[TBL] [Abstract][Full Text] [Related]
7. A simple and effective strategy to increase the sensitivity of fluorescence probes in living cells.
Izumi S; Urano Y; Hanaoka K; Terai T; Nagano T
J Am Chem Soc; 2009 Jul; 131(29):10189-200. PubMed ID: 19572714
[TBL] [Abstract][Full Text] [Related]
8. High throughput screening assay for UDP-glucuronosyltransferase 1A1 glucuronidation profiling.
Trubetskoy OV; Finel M; Kurkela M; Fitzgerald M; Peters NR; Hoffman FM; Trubetskoy VS
Assay Drug Dev Technol; 2007 Jun; 5(3):343-54. PubMed ID: 17638534
[TBL] [Abstract][Full Text] [Related]
9. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.
Uchaipichat V; Mackenzie PI; Elliot DJ; Miners JO
Drug Metab Dispos; 2006 Mar; 34(3):449-56. PubMed ID: 16381668
[TBL] [Abstract][Full Text] [Related]
11. Automation and miniaturization of the bioluminescent UGT-Glo assay for screening of UDP-glucuronosyltransferase inhibition by various compounds.
Larson B; Kelts JL; Banks P; Cali JJ
J Lab Autom; 2011 Feb; 16(1):38-46. PubMed ID: 21609684
[TBL] [Abstract][Full Text] [Related]
12. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.
Miners JO; Mackenzie PI; Knights KM
Drug Metab Rev; 2010 Feb; 42(1):196-208. PubMed ID: 19795925
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibitors of the human UDP-glucuronosyltransferase 2B7 derived from the sesquiterpenoid alcohol longifolol.
Bichlmaier I; Kurkela M; Joshi T; Siiskonen A; Rüffer T; Lang H; Finel M; Yli-Kauhaluoma J
ChemMedChem; 2007 Jun; 2(6):881-9. PubMed ID: 17479992
[TBL] [Abstract][Full Text] [Related]
14. pH fluorescent probes: chlorinated fluoresceins.
Ge FY; Chen LG
J Fluoresc; 2008; 18(3-4):741-7. PubMed ID: 18157737
[TBL] [Abstract][Full Text] [Related]
15. Chemical Probes for Human UDP-Glucuronosyltransferases: A Comprehensive Review.
Lv X; Zhang JB; Hou J; Dou TY; Ge GB; Hu WZ; Yang L
Biotechnol J; 2019 Jan; 14(1):e1800002. PubMed ID: 30192065
[TBL] [Abstract][Full Text] [Related]
16. A universal radiochemical high-performance liquid chromatographic assay for the determination of UDP-glucuronosyltransferase activity.
Ethell BT; Anderson GD; Beaumont K; Rance DJ; Burchell B
Anal Biochem; 1998 Jan; 255(1):142-7. PubMed ID: 9448853
[TBL] [Abstract][Full Text] [Related]
17. Stereochemical and steric control of the UDP-glucuronosyltransferase-catalyzed conjugation reaction: a rational approach for the design of inhibitors for the human UGT2B7.
Bichlmaier I; Finel M; Sippl W; Yli-Kauhaluoma J
ChemMedChem; 2007 Dec; 2(12):1730-40. PubMed ID: 17943712
[TBL] [Abstract][Full Text] [Related]
18. Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay.
Di Marco A; D'Antoni M; Attaccalite S; Carotenuto P; Laufer R
Drug Metab Dispos; 2005 Jun; 33(6):812-9. PubMed ID: 15788539
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening technologies for drug glucuronidation profiling.
Trubetskoy O; Finel M; Trubetskoy V
J Pharm Pharmacol; 2008 Aug; 60(8):1061-7. PubMed ID: 18644198
[TBL] [Abstract][Full Text] [Related]
20. A versatile fluorescence turn-on assay for highly sensitive detection of tyrosine phosphatase activity.
Liu C; Wang F; Wang Y; Li Z
Chem Commun (Camb); 2014 Nov; 50(90):13983-6. PubMed ID: 25266959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
